27.09.2012
- Danish biopharma company Neurosearch said on Thursday it had signed a 149 million Danish crowns ($25.7 million) deal with Israel's Teva Pharmaceutical Industries for the sale of...
25.09.2012
- Pharmaceuticals - Of the many challenges inherent with biosimilar development, the inability to predict market expectations may top the list for decision makers. While uncertainty...
30.08.2012
- U.S. drug regulators gave the nod to a Teva Pharmaceutical Industries drug that boosts the production of infection-fighting white blood cells in certain cancer patients receiving...
02.06.2012
- The chairman of Teva Pharmaceutical Industries has purchased 1 million U.S.-listed shares of the world's largest generic drugmaker, the company said on Friday. Board Chairman...
30.05.2012
- German generic drugmaker Stada said rivals' growing appetite for takeovers is spurring it to also seek acquisitions as the industry goes for size to cut costs and compete on price...
30.05.2012
- Norway's Pronova BioPharma , which supplies the omega-3 heart medicine Lovaza to GlaxoSmithKline, has defeated a U.S. patent challenge from two generics companies. The victory over...
09.05.2012
- Teva Pharmaceutical Industries posted a 40 % jump in quarterly profit that beat estimates, boosted by robust sales of its own-branded products and generic medicines in the United...
20.04.2012
- European regulators have endorsed the continued use of Novartis's multiple sclerosis pill Gilenya, one of the Swiss firm's top new drug hopes, but said on Friday the drug needed to...
